Wedbush maintains BridgeBio Oncology price target at $25.00
Wedbush maintained its BridgeBio Oncology price target at $25.00 per share, according to Benzinga’s ratings action summary.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.